Challenging conventional karyotyping by next-generation karyotyping in 281 intensively treated patients with AML.
Mareschal S, Palau A, Lindberg J, Ruminy P, Nilsson C, Bengtzén S, Engvall M, Eriksson A, Neddermeyer A, Marchand V, Jansson M, Björklund M, Jardin F, Rantalainen M, Lennartsson A, Cavelier L, Grönberg H, Lehmann S.
Mareschal S, et al. Among authors: nilsson c.
Blood Adv. 2021 Feb 23;5(4):1003-1016. doi: 10.1182/bloodadvances.2020002517.
Blood Adv. 2021.
PMID: 33591326
Free PMC article.